Mollica V.; Di Nunno V.; Santoni M.; Cimadamore A.; Scarpelli M.; Lopez-Beltran A.; Cheng L.; Mariani C.; Battelli N.; Montironi R.; Massari F., An evaluation of current prostate cancer diagnostic approaches with emphasis on liquid biopsies and prostate cancer, «EXPERT REVIEW OF MOLECULAR DIAGNOSTICS», 2020, 20, pp. 207 - 217 [Scientific article]
Aurilio G.; Cimadamore A.; Mazzucchelli R.; Lopez-Beltran A.; Verri E.; Scarpelli M.; Massari F.; Cheng L.; Santoni M.; Montironi R., Androgen Receptor Signaling Pathway in Prostate Cancer: From Genetics to Clinical Applications, «CELLS», 2020, 9, Article number: 2653 , pp. 1 - 14 [Scientific article]Open Access
Vitale G.; Lamberti G.; Comito F.; Di Nunno V.; Massari F.; Morelli M.C.; Ardizzoni A.; Gelsomino F., Anti-programmed cell death-1 and anti-programmed cell death ligand-1 immune-related liver diseases: from clinical pivotal studies to real-life experience, «EXPERT OPINION ON BIOLOGICAL THERAPY», 2020, 20, pp. 1047 - 1059 [Scientific article]
Mollica V.; Rizzo A.; Massari F., Avelumab maintenance for urothelial carcinoma, «THE NEW ENGLAND JOURNAL OF MEDICINE», 2020, 383, pp. 2482 - 2483 [Scientific article]
Di Nunno V.; Mollica V.; Massari F.; De Wit R.; De Bono J.; Castellano D., Cabazitaxel in metastatic prostate cancer, «THE NEW ENGLAND JOURNAL OF MEDICINE», 2020, 382, pp. 1286 - 1286 [Scientific article]
Iacovelli R.; Ciccarese C.; Facchini G.; Milella M.; Urbano F.; Basso U.; De Giorgi U.; Sabbatini R.; Santini D.; Berardi R.; Santoni M.; Bracarda S.; Massari F.; Masini C.; De Tursi M.; Ricotta R.; Buti S.; Zustovich F.; Sepe P.; Rossetti S.; Maruzzo M.; Cortesi E.; Tortora G.; Procopio G., Cabozantinib After a Previous Immune Checkpoint Inhibitor in Metastatic Renal Cell Carcinoma: A Retrospective Multi-Institutional Analysis, «TARGETED ONCOLOGY», 2020, 15, pp. 495 - 501 [Scientific article]
Mollica V.; Maggio I.; Lopez-Beltran A.; Montironi R.; Cimadamore A.; Cheng L.; Rizzo A.; Giunchi F.; Schiavina R.; Fiorentino M.; Brunocilla E.; Massari F., Combination therapy in advanced urothelial cancer: the role of PARP, HER-2 and mTOR inhibitors, «EXPERT REVIEW OF ANTICANCER THERAPY», 2020, 20, pp. 755 - 763 [Scientific article]
Iacovelli R.; Ciccarese C.; Facchini G.; Milella M.; Urbano F.; Basso U.; De Giorgi U.; Sabbatini R.; Santini D.; Berardi R.; Santoni M.; Bracarda S.; Massari F.; Masini C.; De Tursi M.; Ricotta R.; Buti S.; Zustovich F.; Sepe P.; Rossetti S.; Maruzzo M.; Cortesi E.; Tortora G.; Procopio G., Correction to: Cabozantinib After a Previous Immune Checkpoint Inhibitor in Metastatic Renal Cell Carcinoma: A Retrospective Multi-Institutional Analysis (Targeted Oncology, (2020), 15, 4, (495-501), 10.1007/s11523-020-00732-y), «TARGETED ONCOLOGY», 2020, 15, pp. 691 - 691 [Scientific article]
Lopez-Beltran A.; Cheng L.; Gevaert T.; Blanca A.; Cimadamore A.; Santoni M.; Massari F.; Scarpelli M.; Raspollini M.R.; Montironi R., Current and emerging bladder cancer biomarkers with an emphasis on urine biomarkers, «EXPERT REVIEW OF MOLECULAR DIAGNOSTICS», 2020, 20, pp. 231 - 243 [Scientific article]
Mollica V.; Rizzo A.; Montironi R.; Cheng L.; Giunchi F.; Schiavina R.; Santoni M.; Fiorentino M.; Lopez-Beltran A.; Brunocilla E.; Brandi G.; Massari F., Current strategies and novel therapeutic approaches for metastatic urothelial carcinoma, «CANCERS», 2020, 12, Article number: 1449 , pp. 1 - 6 [Scientific article]Open Access
Santoni M.; Massari F.; Aurilio G.; Mollica V.; Cimadamore A.; Lopez-Beltran A.; Cheng L.; Battelli N.; Nole F.; Montironi R., Designing novel immunocombinations in metastatic renal cell carcinoma, «IMMUNOTHERAPY», 2020, 12, pp. 1257 - 1268 [Scientific article]
Giunchi, Francesca; Massari, Francesco; Altimari, Annalisa; Gruppioni, Elisa; Nobili, Elisabetta; Fiorentino, Michelangelo; Ardizzoni, Andrea, Dual TMPRSS2:ERG Fusion in a Patient with Lung and Prostate Cancers, «DIAGNOSTICS», 2020, 10, Article number: 1109 , pp. 1 - 5 [Scientific article]Open Access
Ge R.; Wang Z.; Montironi R.; Jiang Z.; Cheng M.; Santoni M.; Huang K.; Massari F.; Lu X.; Cimadamore A.; Lopez-Beltran A.; Cheng L., Epigenetic modulations and lineage plasticity in advanced prostate cancer, «ANNALS OF ONCOLOGY», 2020, 31, pp. 470 - 479 [Scientific article]
Cimadamore A.; Lopez-Beltran A.; Massari F.; Santoni M.; Mazzucchelli R.; Scarpelli M.; Galosi A.B.; Cheng L.; Montironi R., Germline and somatic mutations in prostate cancer: Focus on defective DNA repair, PARP inhibitors and immunotherapy, «FUTURE ONCOLOGY», 2020, 16, pp. 75 - 80 [Scientific article]
G Brandi, M Deserti, A Palloni, D Turchetti, R Zuntini, F Pedica, G Frega, S De Lorenzo, F Abbati, A Rizzo, M Di Marco, F Massari, S Tavolari, INTRAHEPATIC CHOLANGIOCARCINOMA DEVELOPMENT IN A PATIENT WITH A NOVEL BAP1 GERMLINE MUTATION AND LOW EXPOSURE TO ASBESTOS, «CANCER GENETICS», 2020, 248, pp. 57 - 62 [Scientific article]Open Access